欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0113/003
药品名称BOTOX 200 Allergan Units, Powder for Solution for Injection
活性成分
    • botulinum toxin 200.0 IU
剂型Powder for solution for injection
上市许可持有人Allergan Pharmaceuticals Ireland Castlebar Road Westport County Mayo Ireland
参考成员国 - 产品名称Ireland (IE)
BOTOX 200 Allergan Units Powder for solution for injection
互认成员国 - 产品名称
    • France (FR)
    • Poland (PL)
    • Bulgaria (BG)
    • Romania (RO)
    • Germany (DE)
      BOTOX 200 Allergan-Einheiten, Pulver zur Herstellung einer Injektionslösung
    • Denmark (DK)
      Botox
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
      BOTOX 200 Allergan-Einheiten Pulver zur Herstellung einer Injektionslösung
    • Spain (ES)
    • Portugal (PT)
      Botox
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Botox
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
      Botox 200 Allergan vienības pulveris injekciju šķīduma pagatavošanai
    • Lithuania (LT)
      BOTOX 200 Allergan vienetų milteliai injekciniam tirpalui
    • Estonia (EE)
      BOTOX
    • Hungary (HU)
      BOTOX 200 ALLERGAN egység por oldatos injekcióhoz
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2010/02/18
最近更新日期2024/08/12
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Other
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase